FGF9 and metabolic dysfunction-associated steatohepatitis: To further explore the role of FGF9 in the induction of fibrosis and NASH‐driven HCC, a subcutaneous xenograft model in nude mice and a mouse model of HFHC diet‐induced NASH were introduced.